Equities

PW Medtech Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

PW Medtech Group Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)1.34
  • Today's Change0.00 / 0.00%
  • Shares traded388.00k
  • 1 Year change+44.09%
  • Beta0.1932
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)955.80m
  • Net income in HKD165.81m
  • Incorporated2011
  • Employees1.36k
  • Location
    PW Medtech Group LtdLevel 54Hopewell Centre, 183 Queen's Road EastBEIJING 101204ChinaCHN
  • Phone+86 1 084783617
  • Fax+86 1 084783657
  • Websitehttps://www.pwmedtech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Gaush Meditech Ltd1.63bn115.27m1.05bn819.009.030.54675.060.6430.78390.783911.0912.950.5352.089.051,842,149.003.62-1.534.67-2.2047.2947.666.77-2.901.578.160.2188--1.585.24-46.75--79.78--
Kaisa Health Group Holdings Ltd166.42m-31.22m1.06bn917.00--2.43--6.36-0.0062-0.00620.0330.08650.3086.691.52193,284.50-6.59-7.25-7.83-9.3441.5845.27-21.40-28.203.89--0.0257---0.2824-5.93-720.72---19.69--
Venus MedTech HangZhou Inc483.35m-726.97m1.23bn605.00--0.5264--2.55-1.66-1.661.105.300.12180.90652.08699,497.60-18.34-13.83-21.01-15.5775.8378.74-150.57-151.551.56-32.630.1928---4.1815.08-1.50--11.12--
Beijing Airdoc Technology Co Ltd165.59m-199.82m1.27bn193.00--0.8886--7.64-1.95-1.951.6213.900.10021.572.80587,198.80-12.54-12.40-13.31-13.5466.2956.72-125.12-128.078.71--0.0098---23.3438.74-92.75--1.28--
Shanghai Bio-heart Biologicl Tech Co Ltd23.60m-101.06m1.34bn70.00--2.48--56.73-0.4152-0.41520.0972.220.02510.84353.43374,625.70-11.04-30.86-12.96-32.9946.47---439.71--11.95-1.470.203------50.00--25.75--
Cryofocus Medtech (Shanghai) Co Ltd96.34m-85.99m1.44bn180.00--21.68--14.99-0.3596-0.35960.40290.27220.49451.12--349,075.20-47.93---72.64--67.45---96.93--1.40-54.780.3918--30.72---7.06------
Shanghai HeartCare Medcl Tech Corp Ltd378.92m48.01m1.74bn327.0037.031.4121.164.591.241.249.9332.470.27360.71313.541,101,506.003.47-13.273.66-13.9767.4966.6512.67-90.5013.16--0.0396--19.61--85.51---24.35--
Ethk Labs Inc3.48bn197.13m1.86bn877.009.620.47967.660.53430.12050.12052.132.420.5361.066.844,035,675.003.084.604.866.0422.9421.715.747.170.50955.120.3196--2.406.279.35-1.0810.78--
Sisram Medical Ltd2.70bn160.99m1.89bn1.04k11.730.51785.760.69830.34370.34375.777.780.5491.553.902,662,970.003.905.644.826.6660.9358.957.109.801.73--0.087928.86-2.8315.01-20.233.8741.742.81
PW Medtech Group Ltd955.80m165.81m1.97bn1.36k12.170.4545.432.070.11010.11010.63552.950.16032.9111.47675,476.103.527.714.428.7452.6256.5621.9675.919.12--0.00428.3813.9016.25-1.5712.968.75--
Guanze Medical Infrm Indstry (Hldng) Ltd166.94m23.45m2.84bn58.00121.579.5386.6617.010.02460.02460.17640.31360.50732.211.302,928,807.007.239.508.3312.0436.7941.4314.2513.095.2351.530.054434.79-0.21272.03-37.59-5.0824.24--
Data as of Feb 16 2026. Currency figures normalised to PW Medtech Group Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.72%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 30 Nov 20259.14m0.62%
AXA Investment Managers UK Ltd.as of 31 Dec 2025935.00k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025422.21k0.03%
DFA Australia Ltd.as of 30 Nov 202526.27k0.00%
American Century Investment Management, Inc.as of 30 Sep 20257.00k0.00%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.